Project Grant HT94252510575
Award Date
8/1/25
Completion Date
7/31/28
Dollars Obligated
$2.3M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Bar Harbor, ME 04609, USA
Similar Awards
The Defense Health Agency has awarded a $601,272 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Jackson Laboratory in Bar Harbor, Maine. The grant, with a performance period from August 1, 2025 to July 31, 2028, will fund research to reveal spatial transcriptomic and proteomic shifts in tumor-infiltrating immunocytes, charting a path to enhanced melanoma therapeutics. As a leading nonprofit biomedical research institution, the Jackson Laboratory...
This federal Project Grant award of $276,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research conducted by the Jackson Laboratory in Bar Harbor, Maine. The project aims to develop "whole-brain radiopathomic mapping of glioblastoma infiltration", which will transform healthcare for military service members, veterans, and the broader public by advancing the diagnosis and treatment of this deadly brain cancer. The...
The Defense Health Agency awarded a $754,445 Project Grant to Jackson Laboratory, a nonprofit biomedical research organization, under the Military Medical Research and Development program (CFDA 12.420). The three-year award, effective August 15, 2023 through August 14, 2026, is funding research to target the cGAS-STING axis in order to limit inflammation and neuropathology associated with Gulf War Illness. Jackson Laboratory, located in Bar Harbor, Maine, has extensive experience conducting...
The Defense Health Agency awarded a $1,000,000 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Jackson Laboratory in Bar Harbor, Maine. The grant will support research to uncover spatial and temporal alterations of metabolism in the kidney, which could pave the way for new treatments for lupus nephritis. The project will be conducted over a 3-year period from May 2025 to May 2028. Jackson Laboratory, a nonprofit biomedical research institution,...
This Project Grant award in the amount of $816,375.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The University of Iowa. The grant funds a research project titled "MECHANISMS OF NEURONAL DYSREGULATION UNDERLYING BEHAVIORAL ALTERATIONS IN NEUROFIBROMATOSIS TYPE 1" with a performance period from July 1, 2024 to June 30, 2027. This research aims to investigate the neurological mechanisms underlying behavioral...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $649,000 Project Grant to Rutgers, The State University of New Jersey to conduct research aimed at "Characterizing the Oncogenic Transcriptional Activation During the Malignant Transformation of NF1 Nerve Sheath Tumors." The 3-year award, which commenced on August 1, 2025, supports advanced biomedical research to transform healthcare for military service members, veterans, and the...
This Project Grant award of $894,125.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research to understand and target epigenetic vulnerabilities in neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors (NF1-MPNST) at Washington University. The research aims to transform healthcare for military service members, veterans, and the public by investigating innovative medical solutions. The 3-year...
The U.S. Defense Health Agency awarded a $968,875 Project Grant under CFDA 12.420 "Military Medical Research and Development" to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, Florida. The grant, titled "IDENTIFICATION AND ASSESSMENT OF TARGETS FOR IMMUNOTHERAPY IN NF2-ASSOCIATED SCHWANNOMATOSIS", will fund advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the public. The research will...
This $713,818 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by the Research Institute at Nationwide Children's Hospital in Columbus, Ohio to characterize novel patient-specific modeling systems for NF2 disease research and therapeutic testing. The project will be conducted from September 1, 2024 through August 31, 2027. The Research Institute has extensive experience delivering federal research...
The University of Alabama at Birmingham will use a $148,500 Project Grant from the Defense Health Agency to support research titled "SMART-BASED REPAIR OF NF1 PRE-MRNA." The grant is part of the Military Medical Research and Development program (CFDA 12.420), which aims to transform military and public health care through innovative biomedical research solutions. Specifically, the university will investigate medical solutions for the battlefield by exploring RNA-based therapies to...